Back
 NS  Vol.3 No.4 , April 2011
Possible mechanism of increasing resistance of the myocardium during combination of post infarction remodeling and diabetes mellitus
Abstract: It was shown that the energy metabolism of the heart mitochondria of experimental animals and patients is more resistant to damage at combined postinfarction cardiosclerosis and diabetes in comparison with the individual pathology. We found that the changes of free fatty acid content and conjugation of the processes of oxidation and phosphorylation in heart mitochondria are components of the metabolic stability of myocardium at the combined development of postinfarction cardiosclerosis and diabetes mellitus. Our data demonstrate a direct link between the violations of the processes of oxidative phosphorylation and accumulation of free fatty acids owing to change in activity of endogenous phospholipases, in particularly, mi- tochondrial phospholipase A2. Similar results were obtained for intraoperative biopsy specimens of patients’ hearts, and of adult Wistar rats’ hearts. We hypothesized that the preservation of energy metabolism is a manifestation of summing up of compensatory processes at de- velopment of nonspecific response of cells to damage at the early stages of pathological pro- cess.
Cite this paper: Egorova, M. , Afanasiev, S. , Kondratyeva, D. , Kozlov, B. and Popov, S. (2011) Possible mechanism of increasing resistance of the myocardium during combination of post infarction remodeling and diabetes mellitus. Natural Science, 3, 295-300. doi: 10.4236/ns.2011.34038.
References

[1]   A. A. Aleksandrov, “Diabetic heart: fight for the mitochondria,” Consilium Medicum, Vol. 5, No. 9, 2003, pp. 509-513.http://old.consilium-medicum.com/media/consilium/03_09/509.shtml

[2]   W. B. Kannel and D. L. McGree, “Diabetes and cardiovascular disease. The Framingham study,” JAMA, 1979, Vol. 241, pp. 2035-2038.

[3]   W. C. Stanley, G.D. Lopaschuk and J. G. McCormack, “Regulation of substrate metabolism in diabetic heart,” Cardiovac. Res., 1997, Vol. 34, pp. 25-33.

[4]   T. Nawata, N. Takahashi and T. Oopie, “Cardioprotection by streptozotocin-induced diabetes and insulin against ischemia/reperfusion injury in rats,” J. Cardiovasc. Pharmacol., 2002, Vol. 40, No. 4, pp. 491-500.

[5]   H. Chen, W.L. Shen and X. H. Wang, “Paradoxically enhanced heart tolerance to ischemia in type I diabetes and role of increased osmolarity,” Clin. Exp. Pharmacol. Physiol., 2006, Vol. 33, No. 10, pp. 910-916.

[6]   T. A. Dubiley, T. A. Badova, S. A. Migovan and Yu. E. Rushkevich, “Influence of ischemia/reperfusion on function of isolated heart in rats of different ages with streptozotocin diabetes” Problems of Ageing and Longevity, 2007, Vol. 16 No. 1, pp. 11-21.

[7]   S. A. Afanas'ev, D. S. Kondratieva, L. P. Tsapko, S. V. Popov and R. S. Karpov, “Features inotropic responses of rat myocardium at extrasystolic effect in the combined development of infarction atherosclerosis and diabetes mellitus,” Vestnik Arrhythmology, 2009, Vol. 55, pp. 56-59.

[8]   M. V. Egorova, S. A. Afanas’ev, S. V. Popov and R. S. Karpov, “Adaptive changes at combined development of postinfarction remodeling and diabetes,” Bulletin of Experimental Biology and Medicine, 2010, Vol. 150, No. 8, pp. 132-135.

[9]   D. S. Kondratieva, S. A. Afanas’ev, L. P. Falaleeva and V. P. Shakhov, “Inotropic response of myocardium of rats with postinfarction cardiosclerosis on extrasystolic effect,” Bulletin of Experimental Biology and Medicine, 2005, Vol. 139, No. 6, pp. 613-616.

[10]   F. Pallotti and G. Lenaz, “Isolation and subfractionation of mitochondria from animal cells and tissue culture lines,” Methods Cell Biol., 2001, Vol. 65, pp.1-35.

[11]   D. G. Nicholls, “Bioenergetics. Introduction to the chemiosmotic theory,” Academic Press Inc. Ltd, London, 1982.

[12]   A. Grynberg, “The role of lipids in the metabolism of the heart muscle,” Medikography, 1999, Vol. 21, No. 2, pp. 29-38

[13]   E. N. Mokhova and L. S. Haylova, “Involvement of anion carriers of the inner membrane of mitochondria in the uncoupling action of fatty acids,” Biochemistry (Moscow), 2005, Vol. 70, No. 2, pp. 197-202.

[14]   S. N. Molchanov, S. A. Lyusov, A. V. Govorin and I. V. Neverov, “Serum lipids at various stages and morphofunctional types of heart failure in patients with myocardial infarction,” Russian Cardiology Journal, 2005, No. 2, pp. 18-25.

[15]   M. V. Egorova, S. A. Afanas’ev and S. V. Popov, “The role of phospholipase A2 in the activation of respiration of isolated cardiomyocytes with infarction cardiosclerosis,” Bulletin of Experimental Biology and Medicine, 2008, Vol. 146, No. 12, pp. 631-633.

[16]   “The sequence of events during the development of non-specific cell responses to injury,” In: V. V. Novitsky, E. D. Goldberg, O. I. Urazova Eds., Pathophysiology, Publ. GEOTAR-Media, Moscow, 2010, Vol. 1, pp. 59-62.

[17]   L. D. Lukyanova, “Mitochondrial dysfunction - a typical pathological process, the molecular mechanism of hypoxia,” In: L. D. Lukyanova and I. B. Ushakov, Eds., Problems of hypoxia: molecular, physiological and medical aspects, Publ. “Origins”, Moscow, 2004. pp. 8-18.

[18]   E. I. Maevsky, E. V. Grishina, A. S. Rosenfeld, A. M. Zyakun, M. N. Kondrashova and V. M. Vereshchagina, “Anaerobic formation of succinate and facilitating its oxidation - the possible mechanisms of cell adaptation to hypoxia,” Biophysics, 2000, Vol. 45, No. 3, pp. 509-513.

[19]   C. G. M. Millar, G. F. Baxter and C. Thiemermann, “Protection of the myocardium by ischaemic preconditioning: mechanisms and therapeutic implications,” Pharmacol. Ther., 1996, Vol. 69, pp. 143-151.

[20]   D. M. Yellon, A. Dana and J. M. Walker, “Endogenous myocardial protection: the importance of metabolic adaptation (?preconditioning?),” Medikography, 1999, Vol. 21, No. 2, pp.80-84.

[21]   D. M. Yellon and G. F. Baxter, “A “second window of protection” or delayed preconditioning phenomenon: future horizons for myocardial protection?,” J. Mol. Cell. Cardiol. Medikography, 1995, Vol. 27, pp. 1023-1034.

 
 
Top